Zentiva S.A. Logo

Zentiva S.A.

Develops and distributes affordable generic, OTC, and specialty medicines across Europe.

SCD | RO

Overview

Corporate Details

ISIN(s):
ROSCDBACNOR8
LEI:
254900HN31MYF870PE70
Country:
Romania
Address:
THEODOR PALLADY, 032266 BUCUREȘTI, SECTORUL 3
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Zentiva S.A. is a pan-European pharmaceutical company focused on the development, manufacturing, and distribution of high-quality, affordable medicines. The company's extensive portfolio encompasses generic drugs, over-the-counter (OTC) products, and specialty care medicines, including biosimilars. Serving more than 100 million people across over 30 countries, Zentiva is committed to enhancing public health by increasing access to essential treatments. With a workforce of approximately 5,000 employees, the company emphasizes sustainability and social responsibility in its operations, aiming to provide health and wellbeing for all generations.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-15 16:49
Annual Report
Raport Financiar Trimestrial - RFT
English 550.4 KB
2025-05-15 16:47
Quarterly Report
Raport Financiar Trimestrial - RFT
Romanian 648.8 KB
2025-04-30 16:13
Post-Annual General Meeting Information
Raport curent de informare a investitorilor
Romanian 222.1 KB
2025-04-30 13:55
Annual Report
Raport Financiar Anual - RFA
English 819.1 KB
2025-04-30 13:54
Annual Report
Raport Financiar Anual - RFA
Romanian 702.8 KB
2025-02-28 10:30
Annual / Quarterly Financial Statement
REZULTATE FINANCIARE PRELIMINARE
English 262.6 KB
2025-02-28 10:29
Annual Report
REZULTATE FINANCIARE PRELIMINARE
Romanian 334.2 KB
2025-02-21 14:24
Post-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
Romanian 570.2 KB
2025-02-21 14:02
Post-Annual General Meeting Information
Schimbari in conducerea societatii comerciale - RC09
Romanian 660.1 KB
2024-06-13 16:22
Related Party Transaction
Raportare tranzactii parti afiliate in conformitate cu art.92 ind.3 din Legea 2…
English 128.3 KB
2024-05-15 17:19
Quarterly Report
Raport Financiar Trimestrial - RFT
English 452.7 KB
2024-05-15 17:18
Quarterly Report
Raport Financiar Trimestrial - RFT
Romanian 467.9 KB
2024-04-29 14:28
Post-Annual General Meeting Information
Raport curent de informare a investitorilor
English 111.4 KB
2024-04-29 11:53
Legal Proceedings Report
Litigii in care este implicata societatea comerciala - RC08
English 123.9 KB
2024-03-21 11:05
Pre-Annual General Meeting Information
Convocarea adunarii generale a actionarilor - RC11
English 184.0 KB

Automate Your Workflow. Get a real-time feed of all Zentiva S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Zentiva S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Zentiva S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

OS Therapies Inc Logo
Developing a cancer vaccine to treat HER2-expressing tumors, primarily Osteosarcoma.
United States of America
OSTX
Otsuka Holdings Co., Ltd. Logo
Global healthcare group creating pharmaceuticals and nutraceuticals for worldwide well-being.
Japan
4578
Outlook Therapeutics, Inc. Logo
Developing an ophthalmic bevacizumab to treat retinal diseases like wet AMD.
United States of America
OTLK
Ovid Therapeutics Inc. Logo
Developing targeted small molecule therapies for rare neurological diseases and epilepsies.
United States of America
OVID
Ovoca Bio Plc Logo
Biopharma developing a novel therapy for premenopausal women with low sexual desire (HSDD).
Ireland
OVXA
Oxford Biomedica PLC Logo
A CDMO for cell & gene therapy, providing end-to-end viral vector development & manufacturing.
United Kingdom
OXB
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC Logo
A former biopharma firm that developed non-addictive, cannabinoid-based pain therapies.
United Kingdom
OCTHF
Pacira BioSciences, Inc. Logo
Advancing non-opioid therapies for postsurgical, chronic, and musculoskeletal pain.
United States of America
PCRX
PAINREFORM LTD. Logo
Specialty pharma developing extended-release drugs for post-operative pain management.
United States of America
PRFX
PAION AG Logo
Developed drugs for hospital-based sedation, anesthesia, and critical care.
Germany
PA8

Talk to a Data Expert

Have a question? We'll get back to you promptly.